Eczema Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Eczema Relief
Generic name
ARSENICUM IODATUM, KALI BROMATUM, KALI MURIATICUM, NATRUM BROMATUM, NICCOLUM SULPHURICUM, SULPHUR IODATUM, VIOLA TRICOLOR, ZINCUM BROMATUM.
Manufacturer
OHM PHARMA INC.
Product type
HUMAN OTC DRUG
SPL set ID
92077b39-ed44-4d73-865f-0ec83e994940
SPL ID
d44acb83-411f-5445-e053-2995a90a6760
Version
4
Effective date
2021-12-29
Source export date
2026-11-06
Source partition
2
Source file
https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-06/4dafeb36642dffb72e2138939a956de402f722ea8c14c08cd87068efd3669f01/drug-label-0002-of-0014.json.zip
Source manifest SHA-256
4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run
20261108T063105Z
Imported at
2026-11-08 06:48:53
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS: IF PREGNANT OR BREAST-FEEDING, ask a health care professional before use. If symptoms worsen or persist for more than a week, discontinue use and contact a doctor. ​KEEP OUT OF REACH OF CHILDREN.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.